An endocrinologist with NewYork-Presbyterian/Weill Cornell Medical Center pursues ongoing basic science and clinical investigations into the interactions between the endocrine system and how fructose drives obesity and affects cancer metabolism.

As COVID-19 cases continued to climb, so did the need to bolster the physician ranks by redeploying residents, fellows, and attendings. In the Division of Endocrinology at NewYork-Presbyterian/Columbia University Irving Medical Center, fellows volunteered to go where they were most needed.

Drs. Ortiz-Pujols and Tchang have been exploring the link between obesity and its association with a higher risk of developing severe symptoms and complications of COVID-19. Why are patients with obesity at higher risk of infection in general?

A large percentage of hospitalized patients with COVID-19 have diabetes. Many have hyperglycemia, increased insulin resistance, and even new presentations of diabetes

According to Dr. Lowe, there has been a three-fold increase in thyroid cancer over the past three decades, with more than 50,000 cases in the United States in 2018, mainly driven by the increased number of early-stage papillary thyroid cancers.

Education is a major focus of Aaron Schulman, MD, an endocrinologist in the Division of Endocrinology, Diabetes, and Metabolism and Director of the Endocrinology Fellowship Program at NewYork-Presbyterian/Weill Cornell.

Laura C. Alonso, MD, a noted physician-scientist, has been appointed Chief of the Division of Endocrinology, Diabetes and Metabolism at NYP/WCMC and Director of the newly established Joan and Sanford I. Weill Center for Metabolic Health at WCM.

Doctors at NewYork-Presbyterian/Columbia are looking to interventional endocrinology, an emerging specialty that uses percutaneous, image-guided, less-invasive procedures to address endocrine disorders that offers an alternative to surgery.